Amban, Flordeliza S.
HRN: 23 11 82 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/27/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/27/2023
06/03/2023
IV
500 Mg
Q8h
T/C Acute Appemdicitis
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes